Fact based stock research
Bayer (XTRA:BAYN)

DE000BAY0017

Bayer stock research in summary

bayer.com


Bayer shares have a market-typical stock price level. While they are good value, they show below average growth, and are riskily financed. We recommend evaluating whether the future of the company Bayer is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.


Latest Obermatt Ranks


Country Germany
Industry Pharmaceuticals
Index CDAX, DAX 40, EURO STOXX 50
Size class XX-Large

June 2, 2022. Stock data may be delayed. Login to get the most recent research.



Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bayer from June 2, 2022.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.